CFB and skin squamous cell carcinoma: Together with our previous studies showing the role of FB, C3, FI and FH in AP, and C1r and C1s in the classical pathway in cSCC progression [25,26,27,28,29,30], these results provide further evidence for the role of specific complement components as biomarkers and potential therapeutic targets in cSCC (Figure 6).